2 results were returned
International law firm Bird & Bird has advised Chiesi Farmaceutici S.p.A. ("Chiesi") on the in-licence of Raxone® -- an orphan drug used in the treatment of Leber's hereditary optic neuropathy ("LHON")
Bird & Bird are pleased to announce the promotion of three partners, as well as eight Senior Counsel/Counsel/Legal Directors from across our global offices.
DEFAULT DEFAULT Most Relevant Alphabetical Chronological Go
REFINE RESULTS: